Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Monami: Rosiglitazone and Risk of Cancer. (0.11 sec) 

Rosiglitazone and Risk of Cancer

- diabetesjournals.org [PDF] 
M Monami, C Lamanna, N Marchionni, E … - Diabetes Care, 2008 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS — Randomized clinical trials of rosiglitazone with
duration of24 weeks were retrieved through Medline and from the GlaxoSmithKline
Web site, which reports main results of all trials sponsored by ...
Cited by 5 - Related articles - All 10 versions

[CITATION] Cancer mortality and insulin glargine


Z Bloomgarden, Y Handelsman - Journal of Diabetes, 2009 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Related articles

Troglitazone inhibits histone deacetylase activity in breast cancer cells


GF Davies, AR Ross, TG Arnason, BHJ … - Cancer Letters, 2009 - Elsevier
We previously demonstrated that the PPARγ agonist Troglitazone (TRG), a potent
antiproliferative agent, in combination with the anthracycline antibiotic
Doxorubicin (DOX), is an effective killer of multiple drug resistant (MDR) ...
Related articles - All 2 versions

Sulphonylureas and cancer: a case–control study


M Monami, C Lamanna, D Balzi, N Marchionni … - Acta Diabetologica - Springer
Abstract This study was aimed at the assessment of incidence of malignancies in
type 2 diabetic patients trea- ted with different sulphonylureas. A matched
case–control study was performed. Cases were 195 diabetic patients aged ...
Related articles - All 2 versions

Obesity and Breast Cancer: The Roles of Peroxisome Proliferator-Activated Receptor-γ and …


C Jennifer… - PPAR research, 2009 - hindawi.com
Breast cancer is the most prominent cancer among females in the United States.
There are a number of risk factors associated with development of breast cancer,
including consumption of a high-fat diet and obesity. Plasminogen activator ...
Related articles - Cached - All 15 versions

Thiazolidinediones associated with recurrent pleural effusions post coronary artery bypass …


MH Abdallah, PB Khalil, G Jamaleddine, I … - International journal of cardiology, 2006 - Elsevier
A 61-year-old man with diabetes mellitus, of 10 years duration, underwent
cardiac catheterization because of chest pain which showed three vessel disease
with normal left ventricular function. His medications for the past 4 years ...
Cited by 1 - Related articles - All 6 versions

Adiponectin receptor-1 expression is decreased in the pancreas of obese mice


TE Wade, A Mathur, D Lu, DA Swartz-Basile, … - Journal of Surgical Research, 2009 - Elsevier
Obesity is epidemic in the 21st century and has been shown to be a risk factor
for developing severe acute pancreatitis. Adipose tissue produces small
molecules called adipokines, which are important in modulating metabolism ...
Cited by 2 - Related articles - All 30 versions

[PDF] Troglitazone reverses the multiple drug resistance phenotype in cancer cells


GF Davies, BHJ Juurlink, TAA Harkness - Drug Design, Development and Therapy, 2009 - dovepress.com
© 2009 Davies et al, publisher and licensee Dove Medical Press Ltd. This is an
Open Access article which permits unrestricted noncommercial use, provided the
original work is properly cited. ... Gerald F Davies1 Bernhard HJ ...
Cited by 1 - Related articles - View as HTML - All 2 versions

Retrospective Analysis of Rosiglitazone and Macular Oedema in Patients with Type 2 …

- adisonline.com [PDF] 
P Tatti, F Arrigoni, A Longobardi, F Costanza, … - Clinical drug investigation, 2008 - ingentaconnect.com
Page 1. Clin Drug Invest 2008; 28 (5): 327-332 O RIGINAL R ESEARCH A RTICLE
1173-2563/08/0005-0327/$48.00/0 © 2008 Adis Data Information BV. ...
Cited by 1 - Related articles - BL Direct - All 5 versions

Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth …


WG Jiang, G Davies, H Kynaston, MD Mason, … - International journal of molecular medicine, 2006 - ncbi.nlm.nih.gov
Com-1, candidate of metastasis-1, also known as p8, has been shown to regulate
the growth and apoptosis of cancer cells and is associated with the disease
progression in human cancers including prostate cancer. In the current ...
Cited by 1 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google